A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay

References

• Apisarnthanarak A, Mundy LM. Etiology of community-acquired pneumonia. Clin Chest Med 2005;26:47–55
   PubMed Web of Science ®Google Scholar
• Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community-acquired pneumonia. Clin Ther 1998;20:820–37
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Available at: http://www.cdc.gov/nchs/data/series/sr_13/sr13_162.pdf.
   Google Scholar
• Lave JR, Lin CJ, Fine MJ, Hughes-Cronwick P. The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med 1999;20:189–97
   Google Scholar
• Merchant S, Mullins CD, Shih Y-CT. Factors associated with hospitalization costs for patients with community-acquired pneumonia. Clin Ther 2003;25:593–610
   Google Scholar
• Van Cutsem O, Merrill WM. Aerobic Gram-Positive Pneumonia. Philadelphia, PA: B.C. Decker, Inc., 1991
   Google Scholar
• Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier, 2005:833
   Google Scholar
• Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 2002;162:682–8
   Google Scholar
• Mitka M. JCAHO tweaks emergency departments’ pneumonia treatment standards. JAMA 2007;297:1758–9
   PubMed Web of Science ®Google Scholar
• Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405–33
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, AnZueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27–72
   PubMed Web of Science ®Google Scholar
• Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000;283:749–55
   PubMed Web of Science ®Google Scholar
• Capelastegui A, Espana PP, Quintana JM, et al. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis 2004;39:955–63
   PubMed Web of Science ®Google Scholar
• McCormick D, Fine MJ, Coley CM, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med 1999;107:5–12
   PubMed Web of Science ®Google Scholar
• Fine MJ, Pratt HM, Obrosky DS, et al. Relation between length of hospital stay and costs of care for patients with communityacquired pneumonia. Am J Med 2000;109:378–85.
   PubMed Web of Science ®Google Scholar
• Premier homepage available at: http://www.premierinc.com/index.jsp
   Google Scholar
• Kollef MH, Shorr A, Ying P, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854–62
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29:891–8
   PubMed Web of Science ®Google Scholar
• File TM, Jr., Schlemmer B, Garau J, et al. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin. J Antimicrob Chemother 2001;48:67–74
   PubMed Web of Science ®Google Scholar
• Blanchette CM, Wang PF, Joshi AV, et al. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J 2007;16:353–63
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55
   Web of Science ®Google Scholar
• Rubin DB. Matched Sampling for Causal Effects. New York, NY: Cambridge University Press, 2006
   Google Scholar
• Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985;39:33–8
   Web of Science ®Google Scholar
• D’Agostino RB. Tutorial in biostatistics: propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265–81
   PubMed Web of Science ®Google Scholar
• Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13–22
   Google Scholar
• Boos DD. On generalized score tests. Am Stat 1992;46:327–33
   Web of Science ®Google Scholar
• Schneeweiss S. Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther 2007;82:143–56
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Boston R, Farrar JT, Strom BL. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 2003;158:280–7
   PubMed Web of Science ®Google Scholar
• Weingart SN, Wilson RM, Gibberd RW, Harrison B. Epidemiology of medical error. BMJ 2000;320:774–7
   PubMed Web of Science ®Google Scholar
• Davey PG. Cost management in community-acquired lower respiratory tract infection. Am J Med 1995;99(Suppl 6B): 20–3S
   Google Scholar
• Colice GL, Morley MA, Asche C, et al. Treatment costs of community-acquired pneumonia in an employed population. Chest 2004;125:2140–5
   PubMed Web of Science ®Google Scholar